Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

APH Transforms Into Biotechnology Company ICPbio

May 5, 2006

APH Transforms Into Biotechnology Company ICPbio

Statement made by Tracey Lake, Chairman,
Australasian Property Holdings Group

The shareholders of stock exchange listed Australasian Property Holdings Group ( APH ) have agreed to transform the company into a biotechnology company, and the company will be renamed ICP Biotechnology Limited ( ICPbio) once settlement and completion takes place next week.

At a special meeting of shareholders of APH held in Auckland today, shareholders passed a series of resolutions to facilitate the transaction.

The resolutions included

- APH acquiring for $12 million ICPbio, by allocating 80 million shares in APH to the owners of ICPbio
- The conversion of $2 million in liabilities into equity, through the issue of 13.3 million shares in APH to the owners of the debt
- Directors being authorised to raise new capital through the placement of up to 30 million new shares in APH, at no less than 15 cents
- The appointment of major ICPbio shareholder, Dr Earl Stevens, as a director.

Shareholders also agreed to the sale of The Escarpments Project at Katoomba in Australia for not less than $15.55 million. The sale was unlikely to result in any cash surplus.

Subsequent to the meeting, directors agreed to the renaming of APH to ICP Biotechnology Limited, and the appointment of Dr Stevens as Managing Director.

During the meeting Dr Stevens told shareholders that ICPbio is one of New Zealand's longest established biotechnology companies and currently manufactures and markets products for use in animal reproduction, animal health care and the fine biochemicals field.

ICPbio's vision is set on becoming a leading global manufacturer of quality biological products for the biotechnology, animal and human pharmaceutical industries.

Nearly 100% of its products are exported, primarily to North America and Europe, with increasing amounts to Asia and South America.

ICPbio is forecasting revenue of $22.8 million for the financial year ending March 31, 2007, and a net operating profit after tax of $2.1 million.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Mycoplasma Bovis: More Properties Positive

One of the latest infected properties is in the Hastings district, the other three are within a farming enterprise in Winton. The suspect property is near Ashburton. More>>

ALSO:

Manawatū Gorge Alternative: More Work Needed To Choose Route

“We are currently working closely and in partnership with local councils and other stakeholders to make the right long-term decision. It’s vital we have strong support on the new route as it will represent a very significant long-term investment and it will need to serve the region and the country for decades to come.” More>>

ALSO:

RBNZ: Super Fund Chief To Be New Reserve Bank Governor

Adrian Orr has been appointed as Reserve Bank Governor effective from 27 March 2018, Finance Minister Grant Robertson says. More>>

ALSO:

ScoopPro: Helping PR Professionals Get More Out Of Scoop

Scoop.co.nz has been a fixture of New Zealand’s news and Public Relations infrastructure for over 18 years. However, without the financial assistance of those using Scoop in a professional context in key sectors such as Public Relations and media, Scoop will not be able to continue this service... More>>

Insurance: 2017 Worst Year On Record For Weather-Related Losses

The Insurance Council of New Zealand (ICNZ) announced today that 2017 has been the most expensive year on record for weather-related losses, with a total insured-losses value of more than $242 million. More>>

ALSO: